NYSEAMERICAN:CTEK - CynergisTek Stock Price, Forecast & News

CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."

CynergisTek Inc (NYSEAMERICAN:CTEK) posted its quarterly earnings results on Monday, May, 13th. The company reported ($0.09) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.06) by $0.03. The firm had revenue of $5.77 million for the quarter, compared to analysts' expectations of $5.84 million. View CynergisTek's Earnings History.

CynergisTek is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for CynergisTek.

1 brokers have issued 12 month target prices for CynergisTek's shares. Their forecasts range from $7.00 to $7.00. On average, they expect CynergisTek's stock price to reach $7.00 in the next year. This suggests a possible upside of 76.8% from the stock's current price. View Analyst Price Targets for CynergisTek.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CynergisTek in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CynergisTek.

Media stories about CTEK stock have trended somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CynergisTek earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for CynergisTek.

CynergisTek saw a drop in short interest during the month of January. As of January 31st, there was short interest totalling 17,400 shares, a drop of 7.4% from the January 15th total of 18,800 shares. Based on an average trading volume of 27,200 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.2% of the shares of the company are short sold. View CynergisTek's Current Options Chain.

Some companies that are related to CynergisTek include Northbridge Industrial Services (NBI), Energy Technologies (EGY), Continental Materials (CUO), Xeros Technology Group (XSG), International Corona Capital (IC), Tricorn Group (TCN), Chamberlin (CMH), Associated British Engineering (ASBE) and Alstom (ALO).

Based on aggregate information from My MarketBeat watchlists, some companies that other CynergisTek investors own include AcelRx Pharmaceuticals (ACRX), Genocea Biosciences (GNCA), SeaChange International (SEAC), SMTC (SMTX), Invesco (IVZ), Actinium Pharmaceuticals (ATNM), Allena Pharmaceuticals (ALNA), Digi International (DGII), Ichor (ICHR) and Inovio Pharmaceuticals (INO).

CynergisTek's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Perritt Capital Management Inc. (5.17%), King Luther Capital Management Corp (4.29%), Essex Investment Management Co. LLC (1.47%) and Renaissance Technologies LLC (1.05%). Company insiders that own CynergisTek stock include John D Abouchar, Judith Finger Krandel, Mark D Roberson, Paul Thomas Anthony and William Caleb Barlow. View Institutional Ownership Trends for CynergisTek.

CTEK stock was sold by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc. and Renaissance Technologies LLC. View Insider Buying and Selling for CynergisTek.

CTEK stock was acquired by a variety of institutional investors in the last quarter, including King Luther Capital Management Corp and Essex Investment Management Co. LLC. Company insiders that have bought CynergisTek stock in the last two years include John D Abouchar, Judith Finger Krandel, Mark D Roberson, Paul Thomas Anthony and William Caleb Barlow. View Insider Buying and Selling for CynergisTek.

Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CTEK stock can currently be purchased for approximately $3.96.

CynergisTek has a market capitalization of $40.94 million. CynergisTek employs 292 workers across the globe.View Additional Information About CynergisTek.

The official website for CynergisTek is http://www.cynergistek.com/.

The company can be reached via phone at 949-614-0700.